{"id":322677,"date":"2022-05-19T15:54:42","date_gmt":"2022-05-19T13:54:42","guid":{"rendered":"https:\/\/medizinonline.com\/gestao-de-um-novo-tratamento-direccionado-para-a-dermatite-atopica\/"},"modified":"2023-01-12T10:18:28","modified_gmt":"2023-01-12T09:18:28","slug":"gestao-de-um-novo-tratamento-direccionado-para-a-dermatite-atopica","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/gestao-de-um-novo-tratamento-direccionado-para-a-dermatite-atopica\/","title":{"rendered":"Gest\u00e3o de um novo tratamento direccionado para a dermatite at\u00f3pica"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Podem surgir v\u00e1rias quest\u00f5es antes de utilizar um medicamento pela primeira vez. No v\u00eddeo tutorial, o PD Dr. Florian Anzengruber, Kantonsspital Graub\u00fcnden, explica o que deve ser considerado na gest\u00e3o de uma op\u00e7\u00e3o de tratamento recentemente aprovada e direccionada para a dermatite at\u00f3pica moderada a grave.<\/strong><\/p>\n\n\n\n<!--more-->\n\n\n\n<p class=\"wp-block-paragraph\">Com base em resultados positivos de ensaios cl\u00ednicos, o inibidor selectivo de Janus kinase (JAKi) upadacitinib (RINVOQ\u00ae) recebeu aprova\u00e7\u00e3o para o tratamento de doentes adultos com dermatite at\u00f3pica moderada a grave (AD) em 26 de Novembro de 2021 [1-3].<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Informa\u00e7\u00e3o importante sobre o in\u00edcio da terapia e gest\u00e3o do upadacitinib em doentes com AD \u00e9 claramente apresentada pelo dermatologista PD Dr. Florian Anzengruber, Kantonsspital Graub\u00fcnden, no seguinte v\u00eddeo tutorial.<\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Rinvoq_final_KFI-V06_DE.mp4\" data-src=\"https:\/\/player.vimeo.com\/video\/756814027?h=2bc7417a81&amp;dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/www.medizinonline.com\/artikel\/kurzfachinformationen\" target=\"_blank\" rel=\"noopener\"><u>Breve informa\u00e7\u00e3o t\u00e9cnica RINVOQ\u00ae.<\/u><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Com o apoio financeiro da AbbVie AG, Alte Steinhauserstrasse 14, 6330 Cham.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dr. sc. nat. Jennifer Keim<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CH-RNQD-220001_05\/2022<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Contribui\u00e7\u00e3o online desde 31.05.2022<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Publica\u00e7\u00e3o actualizada 04.10.2022<\/p>\n\n\n\n<div><span style=\"font-size: 9px;\">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swissmedicjournal 11\/2021. Dispon\u00edvel em<em> https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/ueber-uns\/publikationen\/swissmedic-journal\/swissmedic-journal-2021.html<\/em>.<\/span><\/div>\n\n\n\n<div><span style=\"font-size: 9px;\">2.&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp;&nbsp; &nbsp; Informa\u00e7\u00e3o t\u00e9cnica actual R <a href=\"www.swissmedicinfo.ch\">INVOQ\u00ae (upadacitinib) em<\/a><\/span><\/div>\n\n\n\n<div><span style=\"font-size: 9px;\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Guttman-Yassky E et al. Upadacitinib uma vez por dia versus placebo em adolescentes e adultos com dermatite at\u00f3pica moderada a grave (Medida 1 e Medida 2): resultados de duas r\u00e9plicas de ensaios da fase 3 controlados aleatoriamente e duplo-cegos. Lancet, 2021. 397(10290): p. 2151-2168.<\/span><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">As refer\u00eancias podem ser solicitadas por profissionais em medinfo.ch@abbvie.com.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Podem surgir v\u00e1rias quest\u00f5es antes de utilizar um medicamento pela primeira vez. No v\u00eddeo tutorial, o PD Dr. Florian Anzengruber, Kantonsspital Graub\u00fcnden, explica o que deve ser considerado na gest\u00e3o&hellip;<\/p>\n","protected":false},"author":14,"featured_media":121418,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"video","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"V\u00eddeo tutorial","footnotes":""},"category":[11339,11551],"tags":[11654],"powerkit_post_featured":[],"class_list":["post-322677","post","type-post","status-publish","format-video","has-post-thumbnail","category-conteudo-do-parceiro","category-rx-pt","tag-noticias-sobre-dermatite-atopica-e-psoriase","post_format-post-format-video","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-04 15:59:13","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":322676,"slug":"gestion-de-un-nuevo-tratamiento-dirigido-para-la-dermatitis-atopica","post_title":"Gesti\u00f3n de un nuevo tratamiento dirigido para la dermatitis at\u00f3pica","href":"https:\/\/medizinonline.com\/es\/gestion-de-un-nuevo-tratamiento-dirigido-para-la-dermatitis-atopica\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/322677","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=322677"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/322677\/revisions"}],"predecessor-version":[{"id":331145,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/322677\/revisions\/331145"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/121418"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=322677"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=322677"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=322677"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=322677"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}